Medical News

RSS

Eribulin from marine sponge inhibits replication of breast cancer cells

For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.

4 May 2015

Frederick Alt honored with 2015 Szent-Györgyi Prize for Progress in Cancer Research

Frederick Alt, PhD, director of the Program in Cellular and Molecular Medicine at Boston Children's Hospital, has been honored with the 2015 Szent-Györgyi Prize for Progress in Cancer Research.

4 May 2015

Novation reports dual-contract award in Bone Densitometry category

Novation today announced its dual-contract award in the Bone Densitometry category. Hologic, Inc. and Swissray International Inc. were both awarded agreements, replacing incumbent GE Healthcare in this category.

4 May 2015

Makindus' MI-100 granted EMA orphan drug designation for treatment of Stargardt's Disease

Makindus, Inc. a specialty pharmaceutical development company focused on ophthalmology announced today that the European Medicines Agency has granted orphan drug designation for their lead candidate, MI-100, for the treatment of Stargardt's Disease.

4 May 2015

Researchers suggest ways to keep harmful tobacco and alcohol products away from young people

As the realities of legalized marijuana take hold in four states and the District of Columbia, legislators and regulators could learn a lot from the successes -- and failures -- of the tobacco and alcohol industries in keeping their harmful products out of the hands of children and adolescents.

4 May 2015

Study shows how pharmacies may play important role in reducing asthma-related illness

A new study shows how pharmacies might collaborate with physicians and families to reduce asthma-related illness.

4 May 2015

Pre-POINT trial raises hope for Type 1 diabetes prevention

Giving oral insulin to children at genetic high risk of diabetes stimulates a regulatory immune response without inducing hypoglycaemia, show the findings of the Pre-POINT study.

1 May 2015

No evidence for cancer risk with growth hormone therapy

There is no evidence that growth hormone (GH) therapy increases the likelihood of neoplasms in children with no additional risk factors, says the Pediatric Endocrine Society Drug and Therapeutics Committee.

1 May 2015

Paediatric primary hyperparathyroidism in rarely a familial disorder

Researchers report that primary hyperparathyroidism in children and adolescents is usually caused by a sporadic single parathyroid adenoma.

1 May 2015

Long-term histrelin implant shows promise for central precocious puberty

Long-term subcutaneous histrelin implant therapy is a viable option for patients with central precocious puberty who require continuous gonadotropin-releasing hormone analogue therapy, say researchers.

1 May 2015

Thyroid ultrasound ‘not highly accurate’ for malignancy in children

Ultrasound has only limited value for diagnosing thyroid cancer in children, say the authors of a meta-analysis.

1 May 2015

Pneumonic plague transmission from dog to man

Pneumonic plague is a rare but life-threatening condition caused by the bacteria Yersinia pestis. Y pestis is usually carried by rodents and can be transmitted to humans through a bite from an infected rodent or rodent flea or inhalation of infectious droplets...

1 May 2015

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

A new vaccine has proven almost completely effective in preventing shingles (disease medical name: herpes zoster), an extremely painful nerve infection which affects a third of Australians; most over the age of 50.

1 May 2015

Karl Storz installs the OR1 NEO® at Spire Harpenden Hopsital

When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre...

From KARL STORZ 1 May 2015

Life expectancy is on the rise in England and Wales, but more so for some than others

In England and Wales, life expectancy is projected to reach 85.7 years for men and 87.6 years for women by 2030, according to findings published in The Lancet...

1 May 2015

Pembrolizumab effective, well-tolerated in advanced melanoma patients

Compared with ipilimumab, treatment with pembrolizumab not only significantly improves outcomes, but also results in fewer high-grade adverse events in patients with advanced melanoma, a phase III trial shows.

30 Apr 2015

Electroclinical triggers for repeat MRI in intractable epilepsy identified

Researchers have outlined the electroclinical features typically associated with bottom-of-sulcus dysplasia, the surgical removal of which often cures epilepsy in affected patients.

30 Apr 2015

Predominant first Alzheimer’s symptoms vary with diagnosis age

The symptoms presented by patients newly diagnosed with Alzheimer’s disease vary with age, with younger patients less likely to have initial memory problems, research shows.

30 Apr 2015

High Throughput ChIP-seq Assay for Genome-wide Protein-DNA Analysis

Chromatrap®, a business unit of Porvair Sciences, has published a new application note that describes how Chromatrap® ChIP-seq assays now enable unbiased, genome-wide understanding of protein-DNA regulatory networks...

From Chromatrap® - Porvair Sciences Ltd 30 Apr 2015

Texas Biomed scientists awarded NIH grant to develop potential HPV-based HIV vaccine

Scientists at Texas Biomedical Research Institute have begun work on a nearly $3.4 million study funded by the National Institutes of Health over the next four years to create an attenuated, or weakened, virus that is a hybrid of the papilloma virus and the human immunodeficiency virus, with the potential to jumpstart a body's immune response to develop antibodies against both viruses.

30 Apr 2015

Medical News

Eribulin from marine sponge inhibits replication of breast cancer cells

Frederick Alt honored with 2015 Szent-Györgyi Prize for Progress in Cancer Research

Novation reports dual-contract award in Bone Densitometry category

Makindus' MI-100 granted EMA orphan drug designation for treatment of Stargardt's Disease

Researchers suggest ways to keep harmful tobacco and alcohol products away from young people

Study shows how pharmacies may play important role in reducing asthma-related illness

Pre-POINT trial raises hope for Type 1 diabetes prevention

No evidence for cancer risk with growth hormone therapy

Paediatric primary hyperparathyroidism in rarely a familial disorder

Long-term histrelin implant shows promise for central precocious puberty

Thyroid ultrasound ‘not highly accurate’ for malignancy in children

Pneumonic plague transmission from dog to man

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

Karl Storz installs the OR1 NEO® at Spire Harpenden Hopsital

Life expectancy is on the rise in England and Wales, but more so for some than others

Pembrolizumab effective, well-tolerated in advanced melanoma patients

Electroclinical triggers for repeat MRI in intractable epilepsy identified

Predominant first Alzheimer’s symptoms vary with diagnosis age

High Throughput ChIP-seq Assay for Genome-wide Protein-DNA Analysis

Texas Biomed scientists awarded NIH grant to develop potential HPV-based HIV vaccine

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News